Gavaruzzi Teresa, Ceccarelli Andrea, Nanni Camilla, Vignali Carloalberto, Colonnello Valentina, Caserotti Marta, Riccò Matteo, Gori Davide
Department of Medical and Surgical Sciences, University of Bologna, 40138 Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.
Vaccines (Basel). 2025 Feb 6;13(2):159. doi: 10.3390/vaccines13020159.
: New strategies for respiratory syncytial virus (RSV) prevention are available and are in development, but their acceptance is crucial to their effectiveness. Objectives: This systematic review aims to summarize current quantitative and qualitative evidence regarding knowledge and attitudes relating to RSV prevention. : Six databases (PubMed, Scopus, APA PsycArticles; APA PsycInfo; CINAHL Complete; Psychology and Behavioral Sciences Collection) and two preprint repositories (medRxiv and Preprints) were searched up until 23 December 2024 (PROSPERO: CRD42024602351). : Sixty-one articles were included, focusing on vaccination for the elderly and adults at risk (n = 10) or pregnant people (n = 24, of which 8 also examined preferences for maternal vs. infant immunization) and infant immunization (n = 27, of which 16 focused on palivizumab, with 6 focusing on adherence to its monthly administration). Eighteen articles assessed attitudes in healthcare professionals. Overall, findings showed limited knowledge and awareness of RSV but generally positive attitudes towards prevention strategies and moderate to high intentions and uptake rates. Protection against the disease and perceived severity promoted acceptance, whereas concerns about side effects hindered it. Maternal vaccination was more acceptable than infant immunization. : Attitudes towards RSV prevention options were generally favorable. Should more options become available, preferences may depend on which options are available, their characteristics, and how they are framed and presented. These insights highlight the importance of education on RSV grounded in decision-making literature, while recognizing the likely favorable reception of preventive measures across target age-populations.
目前已有并正在研发预防呼吸道合胞病毒(RSV)的新策略,但其被接受程度对其有效性至关重要。目的:本系统综述旨在总结当前关于RSV预防的知识和态度的定量和定性证据。方法:检索了六个数据库(PubMed、Scopus、美国心理学会心理学文摘数据库;美国心理学会心理学信息数据库;护理学与健康领域数据库完整版;心理学与行为科学文集)以及两个预印本库(medRxiv和Preprints),检索截至2024年12月23日(国际系统评价注册库:CRD42024602351)。结果:纳入了61篇文章,重点关注老年人和高危成年人的疫苗接种(n = 10)或孕妇(n = 24,其中8篇还研究了母亲与婴儿免疫接种的偏好)以及婴儿免疫接种(n = 27,其中16篇聚焦于帕利珠单抗,6篇关注其每月给药的依从性)。18篇文章评估了医护人员的态度。总体而言,研究结果显示对RSV的知识和认知有限,但对预防策略普遍持积极态度,意愿和接种率中等至高。对疾病的防护和感知到的严重性促进了接受度,而对副作用的担忧则阻碍了接受度。母亲接种疫苗比婴儿免疫接种更易被接受。结论:对RSV预防选项的态度总体上是有利的。如果有更多选项可供选择,偏好可能取决于有哪些选项、它们的特征以及它们的框架和呈现方式。这些见解强调了基于决策文献开展RSV教育的重要性,同时认识到预防措施在目标年龄人群中可能会受到欢迎。